Pear

By Laura Lovett January 7, 2019
On Friday Boston-based Pear Therapeutics announced a whopping $64 million Series C funding. The latest financing was led by Temasek, with participation from Novartis, 5AM Ventures, Arboretum Ventures, Jazz Venture Partners, The Bridge Builders Collaborative and EDBI.  This announcement comes just one year after the digital therapeutic maker landed $50 million in Series B funding.  What they do...
By Dave Muoio November 20, 2018
reSET — a substance use disorder treatment that was the first software-only therapeutic cleared by the FDA — is now commercially available for clinicians to prescribe to their patients, according to a release from Pear Therapeutics and Sandoz, a division of Novartis with which Pear partnered back in April. But while physical prescription drugs are usually handled through a pharmacy, the process...
By Laura Lovett November 6, 2018
When it comes to treating the opioid crisis, digital tools may be able to tackle some of the trickiest issues that the current care model cannot, according to a recently released Rock Health report. The report zeros in on some of the major road blocks in treating addiction and how digital could be the key to addressing these needs.  Those challenges include the variability between treatment...
By Laura Lovett February 1, 2018
The road to FDA clearance for medical devices may change radically in the next year.  Last summer, initial discussion began around implementing a pre-certification program for medical device companies, which would allow certain companies that the FDA has deemed responsible and safe in their development to build products without each new device undergoing the FDA clearance or approval process....
http://pills24.com.ua

Предлагаем www.start-sport.com.ua в любом городе.
http://edu-mns.org.ua/